Antihypertensive Efficacy of Fixed Combination Azilsartan Medoxomil / Chlorthalidone in Patients With Uncontrolled Arterial Hypertension

AIM: To study effects of a fixed azilsartan medoxomil/chlorthalidone combination (Edarbi Clo) on clinical, ambulatory and central blood pressure (BP) in patients with uncontrolled arterial hypertension (AH)). MATERIALS AND METHODS: Patients (n=25) with uncontrolled AH were given fixed azilsartan medoxomil/chlorthalidone combination (40 / 12.5 mg / day) for 4 weeks. After 4 weeks, in patients who did not achieve target BP levels the dose was increased up to 40 / 25 mg / day. Duration of the study was 12 weeks. RESULTS: After 12 weeks of treatment 88 % of patients achieved target clinical BP (.

Editors
-
Journal
Publisher
KlinMed Consulting
Number of issue
11
Language
Russian
Pages
12-18
Status
Published
Department
-
DOI
-
Number
-
Volume
57
Year
2017
Organizations
  • 1 Federal State Autonomous Educational Institution of Higher Education, "Peoples' Friendship University of Russia"
Keywords
azilsartan medoxomil, chlorthalidone, ambulatory blood pressure monitoring, efficacy, safety
Date of creation
19.07.2019
Date of change
19.07.2019
Short link
https://repository.rudn.ru/en/records/article/record/39098/